Welcome to our dedicated page for Avalon Globocare news (Ticker: ALBT), a resource for investors and traders seeking the latest updates and insights on Avalon Globocare stock.
Avalon GloboCare Corp. reports developments across precision diagnostic consumer products, generative AI publishing and software, and related intellectual property. The company markets the KetoAir breathalyzer device, which is registered with the U.S. Food and Drug Administration as a Class I medical device, and it has described plans to extend breathalyzer technology into additional diagnostic uses.
Recurring company updates also cover Avalon Quantum AI LLC, the Catch-Up generative and agentic AI video platform, provisional patent filings for automated commentary systems, and technology collaborations supporting AI media infrastructure. Avalon news also includes capital-structure actions such as private placements, warrant issuances, debenture conversions, shareholder approvals, and Nasdaq compliance matters.
Change Agents (Nasdaq: CHGA) has formed Autonomous Air Defense LLC, a wholly owned subsidiary created to pursue AI-enabled autonomous drone surveillance and counter‑unmanned aerial systems (C‑UAS) technologies. This marks the company’s first concrete step toward entering defense technology and counter‑drone applications, aligned with its recent AI-focused rebranding.
As part of this initiative, Change Agents appointed Major General (Ret.) Malcolm Frost to the advisory boards of both entities. According to Change Agents, the subsidiary will evaluate counter‑drone surveillance and interceptor technologies for potential acquisitions, investments or partnerships. The company cites a C‑UAS market projected to grow from $6.6 billion in 2025 to $20.3 billion in 2030, a ~25% CAGR.
Avalon GloboCare (Nasdaq: ALBT) announced a strategic transformation into a pure-play agentic AI software company and is rebranding as Change Agents Corp.. The company focuses on developing subscription-based AI SaaS platforms that address business problems and automate content creation.
According to Change Agents Corp., its common stock will begin trading on July 22, 2026 on the Nasdaq Capital Market under the new ticker CHGA. Existing shareholders’ ownership and CUSIP remain unchanged, and no action is required. The AI portfolio includes Beacon, an AI Generative Engine Optimization platform expected to launch in late Q3 2026, and Catch-Up, a Phase 2 autonomous content-creation platform being developed with AWS Premier partner Caylent. The company is also evaluating additional AI software opportunities in defense, military, security and other enterprise sectors.
Avalon GloboCare (NASDAQ: ALBT) plans to launch Beacon, a subscription-based Agentic Generative Search Optimization (GEO) platform in late Q3 2026, targeting small businesses that want to improve visibility across AI-powered search engines such as ChatGPT, Gemini, Claude, Perplexity and Grok.
Beacon will be Avalon's second agentic AI software product and is intended to expand its recurring SaaS portfolio alongside the Catch-Up™ agentic video studio platform, which is in Phase 2 development. According to Avalon, Beacon is designed to autonomously analyze a company’s AI search visibility in about 60 seconds, generate competitive gap analyses and optimization recommendations, and produce implementation-ready agent services on an ongoing basis.
The platform is expected to be sold via a recurring monthly subscription, with optional separate services agreements for Avalon to implement Beacon’s AI-generated recommendations, supporting the company’s strategy to build scalable, subscription-based AI software businesses.
Avalon (NASDAQ: ALBT) reported progress in the Nevada POOL/PACT Holistic Health Reset program for 50 first responders, where participants use KetoAir™ for daily breath-based metabolic monitoring.
The four-month initiative, begun in August 2025, shows strong engagement, with average participant engagement around 66% and reported individual improvements in metabolic health metrics.
Avalon GloboCare (NASDAQ: ALBT) appointed Sam Knipper as Chief Financial Officer, effective June 1, 2026, succeeding Luisa Ingargiola.
Ingargiola becomes Chief Strategy Officer. Knipper brings extensive experience in SEC reporting, capital markets, SPACs, AI finance, and previously supported a $40 million equity financing transaction.
Avalon Quantum AI (NASDAQ: ALBT) announced a collaboration with Amazon Web Services and Caylent to support Phase 2 development of its Catch-Up agentic AI video platform on April 21, 2026.
Phase 2 aims to convert the platform from a manually configured tool into a fully autonomous agentic AI video system to help nontechnical creators generate personalized social media video content and scale the SaaS offering.
Avalon (NASDAQ: ALBT) announced on March 31, 2026 that its subsidiary Avalon Quantum AI selected Caylent, an AWS Premier Tier partner, to support phase 2 development of the Catch-Up SaaS platform.
The collaboration aims to evolve Catch-Up from a manually configured AI video production system into a fully autonomous, agentic AI video platform for creators and enterprises.
Avalon GloboCare (NASDAQ: ALBT) closed a private placement priced at-the-market on Feb 27, 2026, selling 6,372,550 shares (or pre-funded warrants) with associated warrants at $0.51 per share, raising approximately $3.25 million of gross proceeds.
The financing includes Series A-1 and A-2 warrants to purchase up to 6,372,550 shares each, exercisable at $0.51 if and when stockholder approval is effective; A-1 expire five years and A-2 expire 18 months from stockholder approval. The company may receive up to ~$6.5 million more if warrants are fully exercised. Net proceeds are intended for debt repayment and working capital.
Avalon GloboCare (NASDAQ: ALBT) entered definitive agreements for a private placement to sell 6,372,550 shares (or pre-funded warrants) and associated Series A-1 and A-2 warrants at $0.51 per share.
The offering is expected to close on or about February 27, 2026, raising approximately $3.25 million in gross proceeds upfront and up to an additional $6.5 million if warrants are fully exercised. Net proceeds will be used to repay certain debt and for working capital.
Avalon GloboCare (NASDAQ: ALBT) was accepted into the AMD AI Developer Program on Feb. 26, 2026, giving its AI subsidiary AQAI access to AMD Developer Cloud credits, tools, training, and community resources.
Avalon plans to use AMD Instinct accelerators and EPYC processors to speed model training, inference, and scalability for automated evidence-constrained video generation, AI-assisted drafting, compliance tooling, and workflow automation.